Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes? - Wikidata - awgldk - TriplyDB

Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

http://www.wikidata.org/entity/Q34613312

about

Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision.Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice Effects of Intraoperative Dexmedetomidine on Postoperative Pain in Highly Nicotine-Dependent Patients After Thoracic Surgery: A Prospective, Randomized, Controlled Trial.Approach to the Complicated Alcohol Withdrawal Patient.Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries.Palonosetron and hydroxyzine pre-treatment reduces the objective signs of experimentally-induced acute opioid withdrawal in humans: a double-blinded, randomized, placebo-controlled crossover study.

P2860

Q36231851-379E7CFE-7C40-4F52-9685-0B404E2CF2A1 Q36244665-81CC426C-EBDF-47DE-8BE1-B05B974392C3 Q36988827-8851D8BF-7E61-484F-B9B9-8A749B1B2752 Q38620815-FF4E7ED2-862D-4216-9E6B-D5E999F663EE Q38718345-B550F010-E079-42A0-B580-6C012D2E5C82 Q39315775-592E8485-CCF3-4E4C-9C9D-95297639E219

P2860

Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?

http://www.wikidata.org/entity/Q34613312

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@ast

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@en

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@nl

type

label

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@ast

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@en

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@nl

prefLabel

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@ast

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@en

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@nl

P1433

Q34613312-48755C41-5545-4D47-845E-F064D49564C0

P1476

Q34613312-E30A5DC2-BE08-4F34-8A00-38CCEDDBF769

P2093

Q34613312-2F6BC688-7426-4652-9AC9-3663C9B21E4F

Q34613312-8D13B2C2-7201-42EF-8406-CCF74841F19B

Q34613312-9BAD7EA3-9943-4E03-A73B-E9876DC05179

Q34613312-A861C589-ED9E-441F-B635-4A7010B6ADD6

Q34613312-F3E86914-326C-4C7E-AE31-23200F3AE618

P2860

Q34613312-01B20192-A6E7-4966-828B-97A0FAF3CA12

Q34613312-052F09C1-6063-42C5-AE45-64EA696384AA

Q34613312-05D41ADE-AACF-463F-86DC-20C4E7DF834C

Q34613312-0BD34334-F3F0-405E-82CC-C256A31DEAD9

Q34613312-0CDDE114-6DA5-4BB4-A25A-CE867E48B7F3

Q34613312-0FCC3C9B-02DB-410A-97CA-ED52666D5E4F

Q34613312-117F102E-A65F-4FAD-BB2A-A2F963BB5CD6

Q34613312-12CECB2E-DB72-4C61-8793-92E023C3F13B

Q34613312-1378ECC8-C3BA-4D6D-B77F-AFAF8E53FA1C

Q34613312-140AA90F-CE7D-49EB-A332-A8B182286042

P2888

Q34613312-9B93A767-3EF3-404E-B2BF-0414C1EA18BE

P304

Q34613312-99EE7C73-F33F-4C6E-98F1-7D101271159F

P31

Q34613312-64e60bbb-2908-4af8-8e47-894a5a9319ad

Q34613312-9442080C-3B2D-4C8B-B681-4A9580B33FF4

P356

Q34613312-17A7DDD9-D350-4AF4-B277-D6D4AC363B33

P433

Q34613312-ACE3FC61-8821-42A0-BE3A-A78DFEDA9D3B

P478

Q34613312-358810F1-22B4-4A63-A673-5879DB888670

P577

Q34613312-1B0D6342-6B66-4862-B4B7-169C8BF67804

P5875

Q34613312-4FBFED33-E9F7-4FDE-864D-23C943483709

P6179

Q34613312-F41E8809-311C-4249-8021-E999126D3D24

P698

Q34613312-78A9C1EB-71E3-4543-B456-9593DF82CF0F

P932

Q34613312-5962FC66-F85A-475C-917A-D6A247C2CBEA

P356

S13181-014-0430-3

P1433

Journal of Medical Toxicology

P1476

Is it prime time for alpha2-ad ...... tment of withdrawal syndromes?

@en

P2093

James Chenoweth

http://www.w3.org/2001/XMLSchema#string

Jonathan Ford

http://www.w3.org/2001/XMLSchema#string

Kelly Owen

http://www.w3.org/2001/XMLSchema#string

Mark E Sutter

http://www.w3.org/2001/XMLSchema#string

Timothy E Albertson

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha2-adrenergic agonists for the management of opioid withdrawal

Pharmacological interventions for smoking cessation: an overview and network meta-analysis

Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery

Clonidine for smoking cessation

Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine

Nicotine addiction

The "stop" and "go" of nicotine dependence: role of GABA and glutamate

Traditional Chinese and Indian medicine in the treatment of opioid-dependence: a review

Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials

Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation

P2888

s13181-014-0430-3

P304

369-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13181-014-0430-3

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265860318

http://www.w3.org/2001/XMLSchema#string

P6179

1008618411

http://www.w3.org/2001/XMLSchema#string

P698

25238670

http://www.w3.org/2001/XMLSchema#string

P932

4252292

http://www.w3.org/2001/XMLSchema#string